UK drug major GSK is considering a bid for a 51 per cent share of India’s Shantha Biotech after European rival Sanofi Aventis pulled out of an acquisition deal last week, according to India’s Economic Times.
http://www.in-pharmatechnologist.com/Industry-Drivers/GSK-may-move-for-51-of-Shantha
wesley says:
Keith says: